Eagle Pharmaceuticals shares are trading lower after the company announced it received notification of deficiency from the Nasdaq regarding the requirement to timely file quarterly report on Form 10-Q. Also, Founder, President and CEO Scott Tarrif...

Eagle Pharmaceuticals, Inc. +0.21%

Eagle Pharmaceuticals, Inc.

EGRX

4.76

+0.21%

Eagle Pharmaceuticals shares are trading lower after the company announced it received notification of deficiency from the Nasdaq regarding the requirement to timely file quarterly report on Form 10-Q. Also, Founder, President and CEO Scott Tarriff announced his resignation effective immediately.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via